Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘eprinomectin’ is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Eprinomectin Eprinomectin B1a All ruminants, equidae 50 μg/kg Muscle NO ENTRY Antiparasitic agents/Agents acting against endo- and ectoparasites’
250 μg/kg Fat
1 500 μg/kg Liver
300 μg/kg Kidney
20 μg/kg Milk
Fin fish 50 μg/kg Muscle and skin in natural proportions
Rabbits 50 μg/kg Muscle
250 μg/kg Fat
1 500 μg/kg Liver
300 μg/kg Kidney

Pharmacologically active Substance	Marker residue	Animal Species	MRLs	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Eprinomectin	Eprinomectin B1a	All ruminants, equidae	50 μg/kg	Muscle	NO ENTRY	Antiparasitic agents/Agents acting against endo- and ectoparasites’
			250 μg/kg	Fat
			1 500 μg/kg	Liver
			300 μg/kg	Kidney
			20 μg/kg	Milk
		Fin fish	50 μg/kg	Muscle and skin in natural proportions
		Rabbits	50 μg/kg	Muscle
			250 μg/kg	Fat
			1 500 μg/kg	Liver
			300 μg/kg	Kidney